QQ客服 官方微博 反馈留言

	UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway
	Ye, Yingyi; Huang, Shuhong; Wu, Yingying
刊名	CANCER MANAGEMENT AND RESEARCH
	2019
卷号	11页码:2339-2348
关键词	cell apoptosis proliferation M14 A375 epithelial-mesenchymal transition
DOI	10.2147/CMAR.S177623
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4547368
专题	山东大学
作者单位	1.Univ Chinese Acad Sci, HwaMei Hosp, Dept Dermatol, Ningbo, Zhejiang, Peoples R China. 2.Shandong Univ, Sch Basic Med Sc
推荐引用方式 GB/T 7714	Ye, Yingyi,Huang, Shuhong,Wu, Yingying. UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway[J]. CANCER MANAGEMENT AND RESEARCH,2019,11:2339-2348.
APA	Ye, Yingyi,Huang, Shuhong,&Wu, Yingying.(2019).UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway.CANCER MANAGEMENT AND RESEARCH,11,2339-2348.
MLA	Ye, Yingyi,et al."UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway".CANCER MANAGEMENT AND RESEARCH 11(2019):2339-2348.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。